Latest by Emily Bass

Long-Acting Injectable Antiretrovirals for PrEP: Will the Tail Wag the Drug?

A medicine you get only every two months to reduce your risk of acquiring HIV could be an option in the future, but only if two clinical trials show that it is safe and effective.

By Mark Mascolini and Emily Bass for AVAC: Global Advocacy for HIV Prevention